Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Béatrice Ferri

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cytokine & Growth Factor Reviews|July 24, 2024
Inflammatory mechanisms of preterm labor and emerging anti-inflammatory interventionsTiffany Habelrih, Thalyssa-Lyn Augustin, Félix Mauffette-Whyte, et al.
Clinics in Perinatology|May 5, 2024
Preventing Preterm Birth: Exploring Innovative SolutionsTiffany Habelrih, Béatrice Ferri, France Côté, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2026
Rytvela, an allosteric modulator of the interleukin-1 receptor, prevents preterm birth and neonatal complications in mice while nifedipine is ineffectiveTiffany Habelrih, Béatrice Ferri, Sarah-Eve Loiselle, et al.
American Journal of Obstetrics and Gynecology|October 16, 2022
Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomesTiffany Habelrih, David-Étienne Tremblay, Erica Di Battista, et al.
EMBO Molecular Medicine|July 3, 2025
A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcomeFrance Côté, Elizabeth Prairie, Estefania Marin Sierra, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cytokine & Growth Factor Reviews|July 24, 2024
Inflammatory mechanisms of preterm labor and emerging anti-inflammatory interventionsTiffany Habelrih, Thalyssa-Lyn Augustin, Félix Mauffette-Whyte, et al.
Clinics in Perinatology|May 5, 2024
Preventing Preterm Birth: Exploring Innovative SolutionsTiffany Habelrih, Béatrice Ferri, France Côté, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2026
Rytvela, an allosteric modulator of the interleukin-1 receptor, prevents preterm birth and neonatal complications in mice while nifedipine is ineffectiveTiffany Habelrih, Béatrice Ferri, Sarah-Eve Loiselle, et al.
American Journal of Obstetrics and Gynecology|October 16, 2022
Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomesTiffany Habelrih, David-Étienne Tremblay, Erica Di Battista, et al.
EMBO Molecular Medicine|July 3, 2025
A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcomeFrance Côté, Elizabeth Prairie, Estefania Marin Sierra, et al.
Pageof 1